What is the recommended treatment for cellulitis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Cellulitis

First-Line Antibiotic Therapy

Beta-lactam monotherapy is the standard of care for typical uncomplicated cellulitis, with a 96% success rate, and MRSA coverage is unnecessary in most cases. 1, 2

Recommended Oral Regimens for Uncomplicated Cellulitis

  • Cephalexin 500 mg four times daily for 5 days 1
  • Dicloxacillin 250-500 mg every 6 hours for 5 days 1, 2
  • Amoxicillin (standard dosing) for 5 days 1, 2
  • Penicillin V 250-500 mg four times daily for 5 days 1
  • Clindamycin 300-450 mg every 6 hours for 5 days (covers both streptococci and MRSA, useful for penicillin allergy) 1, 2

Treatment Duration

Treat for exactly 5 days if clinical improvement occurs; extend only if symptoms have not improved within this timeframe. 1, 2 This represents a major shift from traditional 7-14 day courses and is supported by high-quality randomized controlled trial evidence. 1

When to Add MRSA Coverage

Do NOT routinely add MRSA coverage for typical nonpurulent cellulitis. 1, 2 MRSA is an uncommon cause of typical cellulitis even in high-prevalence settings. 1, 3

Specific Indications for MRSA Coverage

Add MRSA-active antibiotics ONLY when these risk factors are present: 1, 2

  • Penetrating trauma or injection drug use 1
  • Purulent drainage or exudate 1
  • Known MRSA colonization or prior MRSA infection 1
  • Systemic inflammatory response syndrome (SIRS) 1
  • Failure to respond to beta-lactam therapy after 48 hours 1

MRSA-Active Regimens

When MRSA coverage is needed: 1

  • Clindamycin monotherapy 300-450 mg every 6 hours (covers both streptococci and MRSA, but only if local resistance <10%) 1, 2
  • Trimethoprim-sulfamethoxazole PLUS a beta-lactam (e.g., cephalexin) 1
  • Doxycycline 100 mg twice daily PLUS a beta-lactam 1

Critical pitfall: Never use doxycycline or trimethoprim-sulfamethoxazole as monotherapy for cellulitis—their activity against beta-hemolytic streptococci is unreliable. 1, 2

Intravenous Therapy for Hospitalized Patients

Indications for Hospitalization

Admit patients with: 1, 2

  • Systemic inflammatory response syndrome (SIRS), fever, hypotension, or altered mental status 1
  • Severe immunocompromise or neutropenia 1
  • Concern for necrotizing fasciitis or deeper infection 1
  • Failure of outpatient therapy 2

IV Antibiotic Selection

For uncomplicated cellulitis requiring hospitalization (no MRSA risk factors): 1

  • Cefazolin 1-2 g IV every 8 hours (preferred) 1
  • Oxacillin 2 g IV every 6 hours (alternative) 1

For complicated cellulitis or MRSA coverage needed: 1, 2

  • Vancomycin 15-20 mg/kg IV every 8-12 hours (first-line, A-I evidence) 1
  • Linezolid 600 mg IV twice daily (equally effective alternative, A-I evidence) 1
  • Daptomycin 4 mg/kg IV once daily (A-I evidence) 1

Severe Cellulitis with Systemic Toxicity

For signs of systemic toxicity, rapid progression, or suspected necrotizing fasciitis, use mandatory broad-spectrum combination therapy: 1, 2

  • Vancomycin 15-20 mg/kg IV every 8-12 hours PLUS piperacillin-tazobactam 3.375-4.5 g IV every 6 hours 1
  • Alternative: Linezolid PLUS piperacillin-tazobactam 1
  • Alternative: Vancomycin PLUS a carbapenem (meropenem 1 g IV every 8 hours) 1

Duration for severe infections: 7-14 days guided by clinical response, not the standard 5 days. 1

Essential Adjunctive Measures

These are often neglected but critical for treatment success: 1, 2

  • Elevate the affected extremity above heart level for at least 30 minutes three times daily to promote gravity drainage 1, 2
  • Examine and treat interdigital toe spaces for tinea pedis, fissuring, scaling, or maceration 1, 2
  • Address venous insufficiency and lymphedema with compression stockings once acute infection resolves 1, 2
  • Consider systemic corticosteroids (prednisone 40 mg daily for 7 days) in non-diabetic adults, though evidence is limited 1

Special Situations

Bite-Associated Cellulitis

Amoxicillin-clavulanate (Augmentin) 875/125 mg twice daily as monotherapy for animal or human bite-associated cellulitis (provides polymicrobial coverage). 1

Penicillin Allergy

  • Clindamycin 300-450 mg every 6 hours (covers both streptococci and MRSA) 1, 2
  • Levofloxacin 500 mg daily for 5 days (reserve for beta-lactam allergies; does not cover MRSA reliably) 1

Cephalosporin Allergy

  • Penicillin V 250-500 mg four times daily (safe in isolated cephalosporin allergy) 1
  • Clindamycin 300-450 mg every 6 hours 1

Prevention of Recurrent Cellulitis

Annual recurrence rates are 8-20% in patients with previous leg cellulitis. 1

For patients with 3-4 episodes per year despite treating predisposing factors, consider prophylactic antibiotics: 1, 2

  • Penicillin V 250 mg orally twice daily 1, 2
  • Erythromycin 250 mg twice daily 1, 2
  • Intramuscular benzathine penicillin 2

Critical Pitfalls to Avoid

  • Do not add MRSA coverage reflexively simply because the patient is hospitalized—beta-lactam monotherapy succeeds in 96% of typical cases 1, 3, 4
  • Do not extend treatment beyond 5 days unless symptoms have not improved 1, 2
  • Do not use doxycycline or trimethoprim-sulfamethoxazole as monotherapy for typical cellulitis 1
  • Do not delay surgical consultation if necrotizing fasciitis is suspected (severe pain out of proportion to exam, skin anesthesia, rapid progression, gas in tissue, bullous changes) 1
  • Do not miss pseudocellulitis mimics such as venous stasis dermatitis, contact dermatitis, or lymphedema 4

Reassessment and Treatment Failure

Mandatory reassessment in 24-48 hours to verify clinical response. 1 If cellulitis is spreading despite appropriate antibiotics:

  • Reassess for MRSA risk factors 1
  • Evaluate for necrotizing fasciitis (emergent surgical consultation if suspected) 1
  • Consider misdiagnosis (pseudocellulitis, DVT, other mimics) 4
  • Switch to vancomycin or linezolid if MRSA suspected 1

References

Guideline

Management of Cellulitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Treatment of Cellulitis

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Cellulitis: A Review.

JAMA, 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.